Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,582 | 225 | 57.4% |
| Travel and Lodging | $2,778 | 3 | 16.6% |
| Unspecified | $2,286 | 4 | 13.7% |
| Consulting Fee | $2,050 | 2 | 12.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK NRO, Inc. | $4,106 | 24 | $0 (2024) |
| Nevro Corp. | $3,488 | 29 | $0 (2024) |
| Abbott Laboratories | $2,224 | 51 | $0 (2024) |
| Pajunk Medical Systems, LP | $1,600 | 1 | $0 (2022) |
| Nalu Medical, Inc. | $1,402 | 23 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $661.87 | 13 | $0 (2021) |
| Medtronic, Inc. | $508.55 | 5 | $0 (2024) |
| Vertos Medical, Inc. | $395.84 | 5 | $0 (2024) |
| Neuronetics, Inc. | $338.06 | 3 | $0 (2018) |
| Saluda Medical Americas, Inc. | $274.31 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,778 | 67 | BIOTRONIK NRO, Inc. ($4,106) |
| 2023 | $1,271 | 35 | Abbott Laboratories ($434.38) |
| 2022 | $4,667 | 36 | Nevro Corp. ($2,483) |
| 2021 | $1,676 | 39 | Nevro Corp. ($333.60) |
| 2020 | $918.80 | 18 | Abbott Laboratories ($368.43) |
| 2019 | $317.56 | 12 | Amgen Inc. ($113.71) |
| 2018 | $691.52 | 19 | Abbott Laboratories ($295.16) |
| 2017 | $377.03 | 8 | Abbott Laboratories ($227.90) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | BIOTRONIK INC. | Prospera (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Not Applicable | ||||||
| 12/06/2024 | BIOTRONIK INC. | Prospera (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Not Applicable | ||||||
| 12/06/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Not Applicable | ||||||
| 11/22/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $79.45 | General |
| Category: INSTRUMENTS | ||||||
| 11/11/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Pain Management | ||||||
| 11/05/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $59.50 | General |
| Category: Not Applicable | ||||||
| 11/04/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Pain Management | ||||||
| 10/30/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: Not Applicable | ||||||
| 10/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $172.80 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $56.92 | General |
| Category: Not Applicable | ||||||
| 10/05/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $63.44 | General |
| Category: Not Applicable | ||||||
| 10/03/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Pain Management | ||||||
| 10/03/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $144.20 | General |
| Category: Pain Management | ||||||
| 09/26/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Not Applicable | ||||||
| 09/09/2024 | LENOSS MEDICAL INC | Access & Cavity Creation Kit (Device) | Food and Beverage | In-kind items and services | $73.00 | General |
| Category: surgical | ||||||
| 08/30/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $70.23 | General |
| Category: Neuromodulation | ||||||
| 08/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/23/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $87.32 | General |
| Category: Orthopedic | ||||||
| 08/11/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $59.20 | General |
| Category: Not Applicable | ||||||
| 07/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $205.07 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $130.43 | General |
| Category: Neuromodulation | ||||||
| 07/11/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $127.50 | General |
| Category: Orthopedic | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Post Market Observational Study | Nevro Corp. | $2,070 | 2 |
| ECAP Study | Saluda Medical Americas, Inc. | $216.02 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 2,519 | 7,565 | $1.2M | $294,163 |
| 2022 | 35 | 1,747 | 5,203 | $740,203 | $172,603 |
| 2021 | 36 | 2,363 | 8,427 | $1.2M | $311,732 |
| 2020 | 39 | 2,019 | 7,625 | $996,589 | $235,412 |
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 209 | 255 | $287,000 | $61,008 | 21.3% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 11 | 19 | $79,000 | $26,582 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 336 | $61,350 | $22,022 | 35.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 60 | 88 | $88,550 | $16,501 | 18.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 33 | 33 | $56,700 | $15,929 | 28.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 55 | 65 | $35,620 | $12,446 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 124 | $35,310 | $11,586 | 32.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 35 | 55 | $57,000 | $10,589 | 18.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 41 | 48 | $28,800 | $9,170 | 31.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 63 | 112 | $28,000 | $8,336 | 29.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 30 | 30 | $22,800 | $8,095 | 35.5% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 17 | 19 | $23,548 | $8,094 | 34.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 53 | 77 | $33,840 | $7,530 | 22.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 40 | 51 | $27,801 | $7,528 | 27.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 31 | 32 | $22,400 | $6,997 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 49 | $19,630 | $6,650 | 33.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 58 | 64 | $26,880 | $5,512 | 20.5% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 27 | 43 | $18,640 | $4,434 | 23.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 53 | 69 | $34,500 | $4,202 | 12.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 24 | 26 | $20,800 | $3,990 | 19.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 11 | 13 | $9,500 | $3,603 | 37.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 49 | 78 | $33,150 | $3,041 | 9.2% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 28 | 34 | $9,600 | $2,966 | 30.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 17 | 17 | $10,200 | $2,926 | 28.7% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 27 | 34 | $6,800 | $2,831 | 41.6% |
About Dr. David Russo, DO
Dr. David Russo, DO is a Physical Medicine & Rehabilitation healthcare provider based in Hood River, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184604183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Russo, DO has received a total of $16,697 in payments from pharmaceutical and medical device companies, with $6,778 received in 2024. These payments were reported across 234 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,582).
As a Medicare-enrolled provider, Russo has provided services to 8,648 Medicare beneficiaries, totaling 28,820 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Pain Medicine
- Location Hood River, OR
- Active Since 01/18/2006
- Last Updated 09/26/2018
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1184604183
Products in Payments
- Prospera (Device) $4,152
- Omnia (Device) $2,817
- E-CATH PLUS ACC. TSUI (Device) $1,600
- Nalu Neurostimulation System (Device) $1,402
- PROCLAIM (Device) $759.02
- Proclaim Family of SCS IPGs (Device) $650.86
- INTELLIS ADAPTIVESTIM (Device) $481.28
- Senza (Device) $433.78
- mild Device Kit (Device) $395.84
- NEUROSTAR TMS THERAPY (Device) $252.56
- Senza Spinal Cord Stimulation System (Device) $236.77
- ETERNA (Device) $217.69
- ECAP (Device) $216.02
- Superion (Device) $192.37
- NURTEC ODT (Drug) $190.72
- DRG IPGs (Device) $188.17
- Prodigy Family of SCS IPGs (Device) $187.66
- COVEREDGE (Device) $128.60
- WAVEWRITER ALPHA (Device) $126.17
- GENERAL - PAIN MANAGEMENT (Device) $125.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.